• Morgan Stanley (ARVN) broker files Form 144 to sell 24,000 shares Stock Titan Thu, 09 Jul 2026 20:12:54 GMT
• ARVN Stock Jumps 10% After FDA Approves Breast Cancer Drug A Month Ahead Of Schedule Stocktwits Thu, 09 Jul 2026 04:50:41 GMT
• ARVN Stock Drops On CEO Exit — Retail Is Bullish On New Chief’s Credentials, Dismisses Selloff Stocktwits Tue, 07 Jul 2026 20:10:11 GMT
• trading the move, not the narrative: (arvn) edition Stock Traders Daily Sun, 05 Jul 2026 22:10:01 GMT
• arvn stock jumps 10% after fda approves breast cancer drug a month ahead of schedule Stocktwits Thu, 02 Jul 2026 02:15:50 GMT
• Form 4 Arvinas Inc For: 26 June By Investing.com Investing.com Nigeria Sat, 27 Jun 2026 03:12:20 GMT
• form 4 arvinas inc for: 26 june by investing.com Investing.com Canada Fri, 26 Jun 2026 20:31:29 GMT
• director linda bain receives rsus and stock options at arvinas (arvn) Stock Titan Fri, 26 Jun 2026 20:21:24 GMT
• Arvinas (ARVN) director Briggs Morrison granted RSUs and stock options Stock Titan Fri, 26 Jun 2026 07:00:00 GMT
• Arvinas (ARVN) director receives RSU and stock option grants in equity award Stock Titan Fri, 26 Jun 2026 07:00:00 GMT
• Arvinas (NASDAQ: ARVN) director receives RSU and option grants in new Form 4 Stock Titan Fri, 26 Jun 2026 07:00:00 GMT
• Arvinas (ARVN) director receives new RSU and stock option awards Stock Titan Fri, 26 Jun 2026 07:00:00 GMT
• arvinas, inc. (nasdaq: arvn) files form 8-k: key company details, stock info, and compliance disclosures (june 24, 2026) – minicha... Minichart Fri, 26 Jun 2026 04:46:00 GMT
• arvinas inc (arvn) valuation: pe, pb & fair value analysis TradingKey Fri, 26 Jun 2026 02:10:36 GMT
• Arvinas (NASDAQ: ARVN) investors back directors, pay and auditor Stock Titan Thu, 25 Jun 2026 07:00:00 GMT
• arvinas cfo andrew saik sells $46,473 in company stock Investing.com UK Thu, 25 Jun 2026 02:54:15 GMT
• form 4 arvinas inc for: 24 june by investing.com Investing.com Nigeria Wed, 24 Jun 2026 22:35:29 GMT
• arvn: all voting items passed at the virtual meeting, with no shareholder questions submitted TradingView Wed, 24 Jun 2026 14:06:57 GMT
• arvn stock drops on ceo exit — retail is bullish on new chief’s credentials, dismisses selloff Stocktwits Wed, 24 Jun 2026 07:27:38 GMT
• Arvinas CFO Andrew Saik sells $46,473 in company stock Investing.com Wed, 24 Jun 2026 07:00:00 GMT
• ARVINAS (ARVN) CFO auto-sells shares to cover RSU tax withholding Stock Titan Wed, 24 Jun 2026 07:00:00 GMT
• arvinas inc (arvn) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 24 Jun 2026 07:00:00 GMT
• form 144 arvinas inc for: 23 june by investing.com Investing.com Nigeria Tue, 23 Jun 2026 23:07:39 GMT
• arvinas chief medical officer to depart amid company transition Hartford Business Journal Tue, 23 Jun 2026 13:30:28 GMT
• Arvinas Announces Chief Medical Officer Leadership Transition The Globe and Mail Tue, 23 Jun 2026 07:00:00 GMT
• arvinas (nasdaq: arvn) to settle 5,846 vested rsu shares on 06/24/2026 Stock Titan Tue, 23 Jun 2026 07:00:00 GMT
• arvn stock jumps 10% after fda approves breast cancer drug a month ahead of schedule Stocktwits Sun, 21 Jun 2026 19:07:15 GMT
• arvn stock jumps 10% after fda approves breast cancer drug a month ahead of schedule Stocktwits Fri, 19 Jun 2026 16:29:52 GMT
• Arvinas (ARVN) CSO has shares sold automatically to cover RSU tax withholding Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• arvinas, inc. $arvn stock holdings lifted by armistice capital llc MarketBeat Thu, 18 Jun 2026 07:00:00 GMT
• arvinas inc (arvn) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 23:19:48 GMT
• arvinas inc (arvn) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 22:55:00 GMT
• arvinas inc (arvn) earnings forecast: future eps & revenue growth estimates TradingKey Wed, 17 Jun 2026 22:49:06 GMT
• arvinas inc (arvn) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 22:19:52 GMT
• rigel deal for veppanu cleared, arvinas receives payment The Globe and Mail Wed, 17 Jun 2026 22:00:00 GMT
• arvinas inc (arvn) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Wed, 17 Jun 2026 21:59:04 GMT
• arvinas inc (arvn) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 21:54:58 GMT
• arvinas inc (arvn) dividends & stock splits: historical payouts and event timeline TradingKey Wed, 17 Jun 2026 21:21:08 GMT
• arvinas (nasdaq: arvn) insider sells 2,642 shares; may sale of 9,657 noted Stock Titan Wed, 17 Jun 2026 12:59:55 GMT
• rigel to roll out veppanu in august; arvinas, pfizer snag $70m upfront on cleared deal Seeking Alpha Wed, 17 Jun 2026 07:00:00 GMT
• according to a filing submitted to the u.s. securities and exchange commission, biotechnology company arvinas holding company llc,... Bitget Tue, 16 Jun 2026 21:14:45 GMT
• rigel announces closing of licensing agreement for veppanu™ (vepdegestrant) Yahoo! Finance Canada Tue, 16 Jun 2026 20:01:00 GMT
• rigel pays $70m for rights to fda-approved breast cancer drug Stock Titan Tue, 16 Jun 2026 20:01:00 GMT
• according to a document submitted to the u.s. securities and exchange commission, an agreement between arvinas holding company llc... Bitget Tue, 16 Jun 2026 12:48:22 GMT
• Arvinas, Pfizer receive $70M upfront as Rigel deal for VEPPANU clears HSR TradingView Tue, 16 Jun 2026 07:00:00 GMT
• Arvinas (NASDAQ: ARVN) secures $70M VEPPANU payment and major milestones Stock Titan Tue, 16 Jun 2026 07:00:00 GMT
• arvinas inc (arvn) financial health: profitability & balance sheet analysis TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• arvinas inc (arvn) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• arvinas inc (arvn) valuation: pe, pb & fair value analysis TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• arvinas inc (arvn) risk assessment: volatility, financial risk & investment risk TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• price-driven insight from (arvn) for rule-based strategy Stock Traders Daily Sat, 13 Jun 2026 19:50:02 GMT
• arvn stock drops on ceo exit — retail is bullish on new chief’s credentials, dismisses selloff Stocktwits Mon, 08 Jun 2026 12:45:26 GMT
• arvn stock jumps 10% after fda approves breast cancer drug a month ahead of schedule Stocktwits Mon, 08 Jun 2026 01:40:23 GMT
• arvn stock drops on ceo exit — retail is bullish on new chief’s credentials, dismisses selloff Stocktwits Fri, 05 Jun 2026 19:18:27 GMT
• arvinas joins the michael j. fox foundation's lite and ppmi programs to advance new therapies targeting lrrk2 for parkinson's dise... marketscreener.com Fri, 05 Jun 2026 11:45:26 GMT
• Arvinas Sharpens Pipeline Focus After First PROTAC Approval, Eyes Key Trial Data Yahoo Finance Fri, 05 Jun 2026 07:00:00 GMT
• Arvinas joins MJFF initiatives to advance LRRK2 research BioWorld News Fri, 05 Jun 2026 07:00:00 GMT
• arvinas, inc. joins the michael j. fox foundation's lite and ppmi programs to advance new therapies targeting lrrk2 for parkinson'... marketscreener.com Thu, 04 Jun 2026 13:38:00 GMT
• arvinas joins michael j. fox foundation lrrk2 consortium to advance protein degrader research geneonline.com Thu, 04 Jun 2026 12:52:58 GMT
• arvinas joins michael j. fox foundation programs to advance arv-102 for parkinson’s treatment. Pluang Thu, 04 Jun 2026 12:52:08 GMT
• Arvinas Joins The Michael J. Fox Foundation’s LITE and PPMI GlobeNewswire Thu, 04 Jun 2026 07:00:00 GMT
• Arvinas joins Michael J. Fox effort to develop new Parkinson's therapies Stock Titan Thu, 04 Jun 2026 07:00:00 GMT
• arvn reiterates by stephens & co. -- price target maintained at $18 GuruFocus Wed, 03 Jun 2026 15:31:16 GMT
• arvn: first protac degrader approved; pipeline prioritization and key milestones drive focus TradingView Wed, 03 Jun 2026 15:18:04 GMT
• arvn financials: revenue breakdown, margins & competitor comparison Intellectia AI Wed, 03 Jun 2026 07:36:33 GMT
• piper sandler maintains arvinas(arvn.us) with buy rating, maintains target price $20 Moomoo Wed, 03 Jun 2026 07:00:00 GMT
• arvinas reprioritizes pipeline, out-licenses arv-806 development The Globe and Mail Wed, 03 Jun 2026 07:00:00 GMT
• arvinas reprioritizes pipeline, to complete arv-806 phase 1 data and seek out-license; cash runway into h2 2028 TradingView Tue, 02 Jun 2026 20:43:01 GMT
• arvinas (arvn) refocuses arv-806 strategy and projects cash runway into second half of 2028 Stock Titan Tue, 02 Jun 2026 07:00:00 GMT
• monaco asset management sam has $833,000 holdings in arvinas, inc. $arvn MarketBeat Mon, 01 Jun 2026 10:20:40 GMT
• arvinas to present at jefferies healthcare conf... | pluang – crypto, stocks, gold & funds Pluang Fri, 29 May 2026 20:24:35 GMT
• Arvinas to Present at Jefferies Global Healthcare Conference GlobeNewswire Fri, 29 May 2026 07:00:00 GMT
• arvinas, inc. to participate in fireside chat at jefferies global healthcare conference on june 3, 2026 Quiver Quantitative Fri, 29 May 2026 07:00:00 GMT
• arvinas leader departs under a pfizer-shaped cloud | apexonco - clinical trials news and analysis Oncology Pipeline Sun, 24 May 2026 09:58:01 GMT
• (arvn) as a liquidity pulse for institutional tactics Stock Traders Daily Fri, 22 May 2026 17:12:02 GMT
• barclays maintains arvinas(arvn.us) with buy rating, maintains target price $20 Moomoo Fri, 22 May 2026 09:34:00 GMT
• arvinas (arvn) ceo reports small automatic share sale for rsu tax withholding Stock Titan Fri, 22 May 2026 07:00:00 GMT
• h.c. wainwright maintains arvinas(arvn.us) with buy rating, maintains target price $18 Moomoo Fri, 22 May 2026 07:00:00 GMT
• arvn stock price, quote & chart | arvinas inc (nasdaq:arvn) ChartMill Thu, 21 May 2026 07:00:00 GMT
• arvinas (nasdaq: arvn) insider sells shares; rsu settlement reported Stock Titan Wed, 20 May 2026 07:00:00 GMT
• Arvinas Employees Give Back During Company-wide Impact Day Yahoo Finance Mon, 18 May 2026 07:00:00 GMT
• Arvinas staff spend a day cooking, cleaning and crafting for patients and kids Stock Titan Mon, 18 May 2026 07:00:00 GMT
• Earnings call transcript: Arvinas Inc. reports Q1 2026 earnings, stock reacts Investing.com Mon, 18 May 2026 07:00:00 GMT
• analysts offer insights on healthcare companies: schott pharma ag & co. kgaa (1sxp) and arvinas holding company (arvn) The Globe and Mail Sun, 17 May 2026 09:39:29 GMT
• analysts just published a bright new outlook for arvinas, inc.'s (nasdaq:arvn) Sahm Sun, 17 May 2026 06:29:34 GMT
• pfizer, arvinas ink licensing deal with rigel for breast cancer therapy MSN Sun, 17 May 2026 00:31:39 GMT
• pfizer, arvinas ink licensing deal with rigel for breast cancer therapy MSN Sat, 16 May 2026 08:16:21 GMT
• Bullish: Analysts Just Made A Noticeable Upgrade To Their Arvinas, Inc. (NASDAQ:ARVN) Forecasts Yahoo Finance Sat, 16 May 2026 07:00:00 GMT
• Analysts Just Published A Bright New Outlook For Arvinas, Inc.'s (NASDAQ:ARVN) simplywall.st Sat, 16 May 2026 07:00:00 GMT
• analysts just made a notable upgrade to their arvinas, inc. (nasdaq:arvn) forecasts Moomoo Sat, 16 May 2026 07:00:00 GMT
• pfizer, arvinas ink licensing deal with rigel for breast cancer therapy MSN Fri, 15 May 2026 10:45:56 GMT
• Rigel Pharmaceuticals Inks Breast Cancer Drug Deal With Arvinas, Pfizer Yahoo Finance Fri, 15 May 2026 07:00:00 GMT
• hc wainwright comments on arvinas' q2 earnings (nasdaq:arvn) MarketBeat Fri, 15 May 2026 07:00:00 GMT
• wedbush maintains arvinas(arvn.us) with hold rating, maintains target price $11 Moomoo Thu, 14 May 2026 17:11:05 GMT
• bofa securities raises price target on arvinas to $16 from $14 marketscreener.com Thu, 14 May 2026 11:47:50 GMT
• these analysts increase their forecasts on arvinas after q1 results Sahm Thu, 14 May 2026 10:54:58 GMT
• Earnings Beat: Arvinas, Inc. (NASDAQ:ARVN) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts Yahoo Finance Thu, 14 May 2026 07:00:00 GMT
• rigel pharmaceuticals (rigl) is up 20.5% after global veppanu rights deal with pfizer, arvinas - has the bull case changed? Yahoo Finance Thu, 14 May 2026 07:00:00 GMT
• vanguard group inc. sells 1,331,629 shares of arvinas, inc. $arvn MarketBeat Thu, 14 May 2026 07:00:00 GMT
• arvinas cso angela cacace sells $95,965 in company stock by investing.com Investing.com India Thu, 14 May 2026 02:52:06 GMT
• wall street analysts think arvinas (arvn) could surge 25.57%: read this before placing a bet MSN Wed, 13 May 2026 23:26:34 GMT
• arvinas buy rating reiterated as analyst highlights pipeline optionality and veppanu deal, maintains $18 price target TipRanks Wed, 13 May 2026 16:22:14 GMT
• h.c. wainwright maintains arvinas(arvn.us) with buy rating, maintains target price $18 Moomoo Wed, 13 May 2026 15:31:00 GMT
• goldman sachs maintains arvinas(arvn.us) with sell rating, maintains target price $6 Moomoo Wed, 13 May 2026 14:31:00 GMT
• arvinas anticipates us arv-102 psp trial by end of 2026 while maintaining cash runway into second half of 2028 MSN Wed, 13 May 2026 14:29:01 GMT
• arvinas, inc. (nasdaq:arvn) q1 2026 earnings call transcript Insider Monkey Wed, 13 May 2026 12:24:36 GMT
• pfizer, arvinas ink licensing deal with rigel for breast cancer therapy MSN Wed, 13 May 2026 09:01:12 GMT
• rigel snaps up breast cancer drug veppanu in up to $405m deal The Pharma Letter Wed, 13 May 2026 07:29:56 GMT
• arvinas earnings beat by $0.03, revenue fell short of estimates Investing.com Nigeria Wed, 13 May 2026 07:29:39 GMT
• New Haven biotech Arvinas signs potential $405M drug licensing deal Hartford Business Journal Wed, 13 May 2026 07:00:00 GMT
• BofA raises Arvinas stock price target on Veppanu out-licensing deal Investing.com Wed, 13 May 2026 07:00:00 GMT
• Rigel Pharmaceuticals Enters an Exclusive Global Licensing Agreement with Arvinas and Pfizer for Veppanu | PharmExec Pharmaceutical Executive Wed, 13 May 2026 07:00:00 GMT
• Arvinas CSO Angela Cacace sells $95,965 in company stock Investing.com Wed, 13 May 2026 07:00:00 GMT
• Arvinas (ARVN) Q1 Loss Of US$0.90 Per Share Challenges Bullish Margin Narratives simplywall.st Wed, 13 May 2026 07:00:00 GMT
Arvinas, Inc(NASDAQ:ARVN) 
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates are ARV-110, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical tri...
Website: http://www.arvinas.com
Founded: 2013
Full Time Employees: 133
Sector: Healthcare
Industry: Biotechnology